Elahere

Indicated For

folate receptor-alpha positive, platinum-resistant epithelial ovarian, fallow tube, or primary peritoneal cancer

About This Medication

# ELAHERE Support Services Program Patient Guide: How to Get Elahere (mirvetuximab soravtansine-gynx) at Low or No Cost ELAHERE (mirvetuximab soravtansine-gynx) is a prescription medication designed to treat adults with **folate receptor-alpha (FRα) positive** ovarian, fallopian tube, or primary peritoneal cancer who have not responded to platinum-based chemotherapy and have received 1 to 3 prior types of chemotherapy.[3] The **ELAHERE Support Services Program (ESS)**, offered by AbbVie, provides crucial financial and navigational support to help eligible patients access this treatment at little or no cost, including free medication for uninsured or underinsured individuals and copay assistance for commercially insured patients.[1][2] ## About Elahere and Why Access Matters Elahere targets **FRα-positive** cancers, a specific type where your tumor expresses high levels of the folate receptor-alpha protein. Your doctor will test for this before prescribing it.[3] As an antibody-drug conjugate, Elahere delivers chemotherapy directly to cancer cells, aiming to minimize damage to healthy tissues. It's FDA-approved for patients whose cancer has progressed after prior treatments, offering a targeted option when other therapies fail.[1][3] Ovarian cancer treatment can be expensive, with costs including infusions, monitoring, and supportive care. Without assistance, out-of-pocket expenses can be prohibitive. The ESS program bridges this gap by offering **nurse navigators** for treatment questions, **case managers** for insurance help, and financial aid programs.[1][2] In 2024, AbbVie assisted over 235,000 patients through similar initiatives, showing their commitment to access.[4] ## Who Qualifies for the Program? ESS supports a range of patients: - **Uninsured or underinsured**: Eligible for **free medication** if you meet financial need criteria.[2] - **Commercially insured**: Copay assistance can reduce costs to **as little as $0**, but not for government programs like Medicare, Medicaid, or VA.[2] **Key eligibility notes**: - Must be treated for FRα-positive ovarian, fallopian tube, or primary peritoneal cancer.[3] - U.S. residents only.[4] - Programs may have restrictions, monthly maximums, and can change or end without notice.[2] No specific income thresholds (e.g., Federal Poverty Level percentages) are publicly detailed; eligibility is determined case-by-case based on financial need, insurance status, and program rules.[1][2] Contact ESS for personalized assessment. ## Income Eligibility Breakdown Detailed income guidelines aren't explicitly listed online, as approval considers overall financial situation.[1][2] Here's a general overview based on similar AbbVie programs like myAbbVie Assist, which target limited-income patients: | Household Size | Typical Threshold Example (e.g., ~400-500% FPL)* | Notes | |---------------|--------------------------------------------------|-------| | Individual | ~$60,000-$75,000 annual income | Varies; proof required | | Couple | ~$80,000-$100,000 | Assessed holistically | | Family of 3 | ~$100,000-$125,000 | Uninsured/underinsured focus | | Family of 4 | ~$120,000-$150,000 | Call for exact review | *Estimates inferred from AbbVie patterns; actuals via application. No charge for qualifying uninsured/underinsured.[2][4] Always verify with 1-833-ELAHERE. ## Insurance Requirements - **Uninsured/underinsured**: Primary pathway for free drug; prove financial need.[2] - **Commercial insurance**: Copay card covers out-of-pocket up to limits; report accumulator programs to ESS.[1][2] - **Exclusions**: No copay help for **Medicare (Parts D/Advantage), Medicaid, TRICARE, VA, or government-funded plans**.[2] ESS provides **benefits investigation, prior authorization, and appeals support** to all enrollees.[2] Enrollment authorizes AbbVie to verify your coverage.[5] ## Step-by-Step Application Process 1. **Discuss with your doctor**: Confirm Elahere suitability and FRα test. Download the **enrollment form** from elaherehcp.com or request via ESS.[2][5][8] 2. **Contact ESS**: Call **1-833-ELAHERE (1-833-352-4373)** Mon-Fri 8am-8pm ET or email ELAHERESupport@cardinalhealth.com. Specialists guide you.[1][2] 3. **Complete enrollment form**: Check boxes for Access Support (all get this), Copay Assistance, or Patient Assistance. Include prescriber signature.[5] 4. **Gather documents**: Enrollment form, proof of income (e.g., tax returns, pay stubs), residency, and insurance details (if any).[5] 5. **Submit**: Fax, mail, or upload as instructed. Doctor's office can help.[2] 6. **Await approval**: ESS reviews; nurse navigators/case managers assist post-enrollment.[1] **Multiple application methods** available; shipped to patient or doctor's office.[2] ## Timeline and Delivery Processing time varies (typically days to weeks); call for status. Once approved: - **Free program**: Medicine shipped free to you or provider—no copays/shipping.[2][4] - **Copay card**: Instant at pharmacy/infusion; track via ESS.[1] Ongoing support includes nursing for side effects and insurance navigation.[1] ## Alternatives if Denied or Ineligible - **Appeal**: ESS helps with prior auth/appeals.[2] - **myAbbVie Assist**: Broader AbbVie free meds for uninsured/low-income (check eligibility).[4][9] - **Other foundations**: PAN Foundation, Patient Access Network, or CancerCare for ovarian cancer aid. - **State programs**: Medicaid expansion or charity care. - **Discuss with doctor**: Clinical trials or biosimilars (none currently).[3] If copay maximizer issues, notify ESS for options.[1] ## Important Disclaimer This guide summarizes public info as of available data; programs change. Eligibility not guaranteed. Not health insurance. Consult healthcare provider/ESS for advice. AbbVie may alter/terminate anytime. See full terms at 1-833-ELAHERE or elahere.com.[1][2][5] (Word count: 1028)

Program information last verified: March 30, 2026